FDA Inspection 1300144 - Novartis Pharmaceuticals Corporation - February 06, 2026

Record Details

This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on February 6, 2026, issued by the New Jersey District Office, covering biologics.

Company: Novartis Pharmaceuticals Corporation
Inspection Date: February 6, 2026
Product Type: Biologics
Office: New Jersey District Office

Open in Dashboard

ID · dda9986d-7403-4915-9abe-66007c22736d

Violation Codes3

21 CFR 211.113(b)21 CFR 211.19221 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.